118 related articles for article (PubMed ID: 9758357)
1. How should corticosteroids be used in the treatment of acute GVHD? EBMT Chronic Leukemia Working Party. European Group for Blood and Marrow Transplantation.
Ruutu T; Hermans J; van Biezen A; Niederwieser D; Gratwohl A; Apperley JF
Bone Marrow Transplant; 1998 Sep; 22(6):614-5. PubMed ID: 9758357
[No Abstract] [Full Text] [Related]
2. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.
Ruutu T; Niederwieser D; Gratwohl A; Apperley JF
Bone Marrow Transplant; 1997 Apr; 19(8):759-64. PubMed ID: 9134165
[TBL] [Abstract][Full Text] [Related]
3. [Digestive manifestations of graft-versus-host disease (GVHD) in bone marrow transplantation, organ transplantation and transfusion].
Li V; Molina L; Michallet M; Hostein J
Gastroenterol Clin Biol; 1992; 16(1):29-36. PubMed ID: 1537479
[No Abstract] [Full Text] [Related]
4. Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody.
Hervé P; Racadot E; Wijdenes J; Flesch M; Tiberghien P; Bordigoni P; Holler E; Powles M; Bourdeau M; Wilmer E
Bone Marrow Transplant; 1991; 7 Suppl 2():149. PubMed ID: 1878688
[No Abstract] [Full Text] [Related]
5. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
6. Fatal rhabdomyolysis as a complication of bone marrow transplantation.
Volin L; Järventie G; Ruutu T
Bone Marrow Transplant; 1990 Jul; 6(1):59-60. PubMed ID: 2390634
[TBL] [Abstract][Full Text] [Related]
7. Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children.
Peters C; Minkov M; Gadner H; Klingebiel T; Vossen J; Locatelli F; Cornish J; Ortega J; Bekasi A; Souillet G; Stary J; Niethammer D; ;
Bone Marrow Transplant; 2000 Aug; 26(4):405-11. PubMed ID: 10982287
[TBL] [Abstract][Full Text] [Related]
8. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD.
Bertz H; Afting M; Kreisel W; Duffner U; Greinwald R; Finke J
Bone Marrow Transplant; 1999 Dec; 24(11):1185-9. PubMed ID: 10642806
[TBL] [Abstract][Full Text] [Related]
10. Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?
Ancín I; Ferrá C; Gallardo D; Peris J; Berlanga J; Gonzalez JR; Virgili N; Grañena A
Bone Marrow Transplant; 2001 Jul; 28(1):39-45. PubMed ID: 11498742
[TBL] [Abstract][Full Text] [Related]
11. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial.
Schmitz N; Beksac M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szerm J; Bradstock K; Buzyn A; Schlegelberger B; Matcham J; Gratwohl A
Haematologica; 2005 May; 90(5):643-8. PubMed ID: 15921379
[TBL] [Abstract][Full Text] [Related]
12. Disseminated nocardiosis in a bone marrow transplant recipient with chronic GVHD.
Bhave AA; Thirunavukkarasu K; Gottlieb DJ; Bradstock K
Bone Marrow Transplant; 1999 Mar; 23(5):519-21. PubMed ID: 10100569
[TBL] [Abstract][Full Text] [Related]
13. Atypical acute graft-versus-host disease.
Shin J; Hong W; Song H; Choi G; Kim YC
Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photopheresis in graft-versus-host disease.
Carcagnì MR; De Aloe G; D'Ascenzo G; Rubegni P; Fimiani M
J Dtsch Dermatol Ges; 2008 Jun; 6(6):451-7. PubMed ID: 18177413
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S
Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281
[TBL] [Abstract][Full Text] [Related]
16. Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease.
Kumar S; Wolf RC; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Litzow MR
Bone Marrow Transplant; 2002 Aug; 30(3):161-5. PubMed ID: 12189534
[TBL] [Abstract][Full Text] [Related]
17. Autogous bone marrow transplantation for childhood acute myeloid leukemia--a European survey. EBMT Working Party on ABMT.
Herve P; Labopin M; Plouvier E; Palut P; Tiberghien P; Gorin N
Bone Marrow Transplant; 1991; 8 Suppl 1():76-9. PubMed ID: 1760652
[No Abstract] [Full Text] [Related]
18. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
[TBL] [Abstract][Full Text] [Related]
19. An old drug for a new disease: pentostatin (Nipent) in acute graft-versus-host disease.
Margolis J; Vogelsang G
Semin Oncol; 2000 Apr; 27(2 Suppl 5):72-7. PubMed ID: 10877057
[TBL] [Abstract][Full Text] [Related]
20. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]